First case of H5 avian influenza reported in B.C.
On Nov. 9, 2024, the BC Centre for Disease Control’s Public-Health Laboratory reported that an an individual in…
Anixa Biosciences and Cleveland Clinic Presented Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine
On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
4-strain meningococcal vaccine tied to reduction in invasive meningitis cases, deaths
On Nov. 7, 2024, researchers reported that Implementation of routine immunization of U.S. adolescents with the quadrivalent (four-strain)…
Vaccine doses allocated to African countries hardest hit by mpox surge
On Nov. 6, 2024, the World Health Organization announced that the Access and Allocation Mechanism (AAM) for mpox…
Scientists track emergence of novel H5N1 flu reassortant in Cambodia
On Nov. 6, 2024, researchers from the Pasteur Institute in Cambodia published a detailed genetic analysis of the…
Recent COVID-19 vaccination tied to lower risk of long COVID
On Nov. 6, 2024, data from the VENUS (Vaccine Effectiveness, Networking, and Universal Safety) study in Japan revealed…
Nasal Swab Tests Predict COVID-19 Disease Severity, Study Finds
On Nov. 6, 2024, researchers from Emory University, in collaboration with scientists at Gladstone Institutes and University of…
Biotechnology | HIV | Infectious Disease | Life Science News | Medicine | Vaccine | WHO
WHO study lists top endemic pathogens for which new vaccines are urgently needed
On Nov. 5, 2024, a World Health Organization (WHO) study published in eBioMedicine named 17 pathogens that regularly…
Artificial Intelligence | Biotechnology | Diagnostics | Genomics | Infectious Disease | Life Science News | Therapeutics | Vaccine
UW–Madison researchers find persistent problems with AI-assisted genomic studies
On Nov. 4, 2024, a team of University of Wisconsin–Madison researchers warned that artificial intelligence tools gaining popularity…
Study revealed stubborn mistrust in COVID-19 vaccine science
On Nov. 4, 2024, a study conducted by researchers from the CUNY Graduate School of Public Health and…
Oregon reported uptick in bird flu in fall migration of wild birds
On Oct. 31, 2024, the Oregon Department of Agriculture reported that bird flu cases are on the rise,…
U.S. detects H5N1 bird flu in a pig for the first time on Oregon Farm
On Oct. 30, 2024, the the U.S. Department of Agriculture (USDA) reported that H5N1 bird flu was confirmed…
WHO and partners activated Global Health Emergency Corps for the first time in response to mpox outbreak
On Oct. 29, 2024, the World Health Organization (WHO) announced that it had, in collaboration with Member States,…
Iowa Health Department reported Resident Death from Lassa fever
On Oct. 28, 2024, the Iowa Department of Health and Human Services (HHS) confirmed the death of a…
H5N1 virus isolated from infected dairy worker is 100% lethal in ferrets, but does not appear to be circulating in nature
On Oct. 28, 2024, University of Wisconsin–Madison researchers reported that a strain of H5N1 avian influenza virus found…
CDC confirmed two human cases of avian influenza in Washington State
On Oct. 24, 2024, the Centers for Disease Control and Prevention (CDC) confirmed that two people who had…
Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and Older
On Oct. 23, 2024, Pfizer announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee…
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
On Oct. 22, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO® (Respiratory…
Egypt certified malaria-free by WHO
On Oct. 20, 2024, the World Health Organization (WHO) announced it had certified Egypt as malaria-free, marking a…
First presumed human infections of avian influenza investigated in Washington state
On Oct. 20, 2024, the Washington State Department of Health announced that four agricultural workers tested positive for…
WHO reported Spike in outbreak of cholera
On Oct. 18, 2024, the World Health Organization (WHO) reported that from January 1 to September 29, 2024,…
Biotechnology | CDC | Diagnostics | Genomics | Influenza | Life Science News | Vaccine
California Department of Public Health Reported 13 Confirmed Human Cases of Bird Flu
On Oct. 18, 2024, the California Department of Public Health (CDPH) reported that a total of 13 human…
FLUBLOK® (Influenza Vaccine) U.S. label updated with one of Sanofi’s largest flu vaccine safety studies in pregnant individuals
On Oct. 16, 2024, The U.S. Food and Drug Administration (FDA) announced it had updated the label for…
Mpox vaccine is safe and generates a robust antibody response in adolescents
On Oct. 16, 2024, a National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Life Science News | Therapeutics | Vaccine
New risks raise pandemic threat on a global scale
On Oct. 14, 2024, the Global Preparedness Monitoring Board (GPMB) released a report that outlined 15 key drivers…
Sabin Vaccine Institute Delivered Marburg Vaccines to Combat Outbreak in Rwanda
On Oct. 12, 2024, the Sabin Vaccine Institute announced it had delivered a second shipment of ~1000 more…
U.S. officials reported Cluster of drug-resistant mpox identified in five states
On Oct. 10, 2024, health officials from the U.S. Centers for Disease Control and Prevention announced they had…
WHO report elevates role of vaccines in addressing antimicrobial resistance
On Oct. 10, 2024, a report by the World Health Organization (WHO) found that vaccines against 24 pathogens…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
Study Found Persistent Infection Could Explain Long COVID in Some People
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
Novavax’s Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Received Authorization in the EU
On Oct. 9, 2024, Novavax announced that the European Commission granted Marketing Authorization for Novavax’s updated 2024-2025 Nuvaxovid™…